Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myriad Genetics: In the eye of the policy storm.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Apr 2010

Gold E Richard, Carbone Julia

Abstract excerpt

From the late 1980s, a storm surrounding the wisdom, ethics, and economics of human gene patents has been brewing. The various winds of concern in this storm touched on the impact of gene patents on basic and clinical research, on health care delivery, and on the ability of public health care systems to provide equal access when faced with costly patented genetic diagnostic tests. Myriad Genetics, Inc., along...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Commerce
Share to Genetics
Share to Health Policy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Services Accessibility

Share to Laboratories

Share to Patents as Topic

Share to Reagent Kits, Diagnostic

Source

Open in PubMed Open full text

Identifiers

PMID: 20393310
DOI: 10.1097/GIM.0b013e3181d72661
PMCID: PMC3037261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myriad Genetics: In the eye of the policy storm.PMID 20393310Read ↗

The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.Semantic proximity Read ↗

Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.Semantic proximity Read ↗

Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad GeneticsSemantic proximity Read ↗

Patents in Genomics and Human GeneticsSemantic proximity Read ↗

Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.Semantic proximity Read ↗

Direct to confusion: lessons learned from marketing BRCA testing.Semantic proximity Read ↗

The fate and future of patents on human genes and genetic diagnostic methods.Semantic proximity Read ↗

Law-medicine interfacing: patenting of human genes and mutations.Semantic proximity Read ↗

Intellectual Property Landscape of the Human GenomeSemantic proximity Read ↗

Legal developments and practical implications of gene patenting on targeted drug discovery and development.Semantic proximity Read ↗

Patents, genomics, research, and diagnostics.Semantic proximity Read ↗

Coverage of new genetic technologies: what matters to insurers?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.